Drug supply notice: Dexamethasone 0.1 per cent (Maxidex) 5ml eye drops

July 8, 2021

There are currently limited supplies of preserved dexamethasone (Maxidex) 0.1 per cent eye drops in a multi-dose container until early August 2021 due to a manufacturing issue. During this period stock will only be available to order directly from Novartis and subject to order limits.

For patients with insufficient supplies until the resupply date, clinicians should consider prescribing an alternative preparation as appropriate. Patients who are on long term treatment should be fully counselled if switched to alternative preparations, particularly preservative free single dose preparations, due to the need to dispose of the unit dose after use.

Please see Maxidex supply disruption information sheet for further details as well as advice and alternative actions for clinical colleagues.  

For more information, please contact the pharmacy department on ext. 5263/3783.